HF
ABCL icon

HRT Financial’s AbCellera Biologics ABCL Stock Holding History

HRT Financial’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.54M Sell
705,506
-529,647
-43% -$2.59M 0.01% 1094
2026
Q1 		$4.31M Buy
1,235,153
+686,722
+125% +$2.47M 0.01% 1096
2025
Q4 		$1.88M Buy
548,431
+111,856
+26% +$499K 0.01% 1346
2025
Q3 		$2.19M Buy
436,575
+65,562
+18% +$289K 0.01% 1093
2025
Q2 		$1.27M Buy
371,013
+177,730
+92% +$442K 0.01% 1141
2025
Q1 		$431K Sell
193,283
-56,943
-23% -$163K ﹤0.01% 1546
2024
Q4 		$733K Buy
250,226
+120,322
+93% +$335K ﹤0.01% 1248
2024
Q3 		$337K Buy
+129,904
New +$360K ﹤0.01% 1757
2024
Q1 		– Sell
-90,562
Closed -$517K – 2204
2023
Q4 		$517K Buy
90,562
+28,361
+46% +$131K ﹤0.01% 1343
2023
Q3 		$286K Sell
62,201
-67,011
-52% -$408K ﹤0.01% 1682
2023
Q2 		$834K Sell
129,212
-427,062
-77% -$2.91M 0.01% 1053
2023
Q1 		$4.19M Buy
+556,274
New +$5.05M 0.05% 300
2022
Q2 		– Sell
-62,568
Closed -$610K – 2840
2022
Q1 		$610K Buy
+62,568
New +$592K ﹤0.01% 1492
2021
Q2 		– Sell
-27,366
Closed -$929K – 2762
2021
Q1 		$929K Buy
+27,366
New +$1.09M 0.01% 1236

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

HRT Financial's ABCL Position: Q2 2026 in Review

HRT Financial reduced its AbCellera Biologics (ABCL) stake by 43% in Q2 2026, selling an estimated $2.59M and leaving 705,506 shares worth $5.54M. The position accounts for 0.01% of the portfolio, ranked #1094.

HRT Financial first reported a position in ABCL in Q1 2021 and has held it in 14 quarters since. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • HRT Financial held 705,506 shares of AbCellera Biologics worth $5.54M as of Q2 2026.
  • HRT Financial sold 529,647 AbCellera Biologics shares in Q2 2026, an estimated $2.59M.
  • AbCellera Biologics made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1094 holding.
  • HRT Financial first reported a position in AbCellera Biologics in Q1 2021 and has held it in 14 quarters since.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.